INVASIVE CANDIDIASIS
Clinical trials for INVASIVE CANDIDIASIS explained in plain language.
Never miss a new study
Get alerted when new INVASIVE CANDIDIASIS trials appear
Sign up with your email to follow new studies for INVASIVE CANDIDIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients: drug may block deadly fungal infections
Disease control CompletedThis study tested a new drug called rezafungin to prevent serious fungal infections in 602 adults receiving a bone marrow transplant. Participants received either rezafungin or the standard antifungal treatment. The goal was to see if rezafungin is safer and more effective at kee…
Matched conditions: INVASIVE CANDIDIASIS
Phase: PHASE3 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New blood tests could catch deadly fungal infections earlier
Diagnosis CompletedThis study looked at whether combining several newer blood tests can detect serious fungal infections (candidemia) faster and more accurately than the standard blood culture method. Researchers tested 2 adult hospital patients suspected of having a fungal infection. The goal is t…
Matched conditions: INVASIVE CANDIDIASIS
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Diagnosis
Last updated May 07, 2026 18:42 UTC
-
ICU patients may need custom doses for fungal infections
Knowledge-focused CompletedThis study looked at how the antifungal drug micafungin behaves in 60 critically ill ICU patients with invasive candidiasis, a serious fungal infection. The goal was to see if standard doses reach effective levels in these patients, since their bodies often process drugs differen…
Matched conditions: INVASIVE CANDIDIASIS
Phase: PHASE4 • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated May 17, 2026 11:37 UTC